StockData
Geron Corp logo

Geron Corp (GERN) stock

GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$0.99−0.01 (-0.91%)

Close on Nov 18, 2026Market cap $636.63MP/E –Yield –

Geron pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Geron's pe ratio was 185.0× on Oct 31, 2016.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2016Oct 31, 2016185.0×–

More Geron figures

See a number that looks wrong?